Table 3 Association of sclerosis with... | American Society of Hematology

Table 3

Association of sclerosis with transplant outcomes

Outcome	HR* (95% CI)	P
Overall mortality	0.87 (0.63–1.19)	.37
Nonrelapse mortality†	1.00 (0.67–1.49)	.99
Recurrent malignancy†	0.85 (0.53–1.34)	.48
Withdrawal of immunosuppressive treatment	0.65 (0.50–0.85)	.001

Outcome	HR* (95% CI)	P
Overall mortality	0.87 (0.63–1.19)	.37
Nonrelapse mortality†	1.00 (0.67–1.49)	.99
Recurrent malignancy†	0.85 (0.53–1.34)	.48
Withdrawal of immunosuppressive treatment	0.65 (0.50–0.85)	.001

Time-dependent analysis including all patients in the study cohort. Adjusted by months from transplantation to chronic GVHD, patient age, disease risk, and thrombocytopenia at time of initial systemic treatment for chronic GVHD.

†

Analyzed among 930 patients with malignancies.

View Large

This Feature Is Available To Subscribers Only